SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Indonesia Energy Corp. Ltd. operates as an oil and gas, exploration, and production company. It engages in oil and gas assets portfolio with a mix between medium-sized producing blocks and exploration blocks with significant resources. Its portfolio includes Kruh, Citarum, and Rangkas Area. The company was founded by James J. Huang and Wirawan Jusuf in 2014 and is headquartered in Jakarta, Indonesia.

Indonesia Energy Corp Ltd

Indonesia Energy Corp Ltd ($INDO) is a top trending energy stock as escalating geopolitical tensions in the Middle East, including reported strikes on oil infrastructure and fears of supply disruption, fuel community speculation about its potential for a major rally, despite active profit-taking and volatility.

Battalion Oil Corp. engages in the acquisition, production, exploration, and development of liquids-rich oil and natural gas assets in the Delaware Basin. The company was founded in 1987 and is headquartered in Houston, TX.

Battalion Oil Corp - Ordinary Shares (New)

Battalion Oil is trending as escalating Middle East tensions drive up oil prices, with the community actively discussing its substantial price action and anticipating a significant short squeeze due to high borrow rates and minimal shares available to short.

AeroVironment, Inc. engages in the design, development, and production of multi-domain robotic systems and related services for government agencies and businesses. It operates through the following business segments: UnCrewed Systems, Loitering Munitions Systems, and MacCready Work. The UnCrewed Systems segment focuses primarily on small UAS products designed to operate reliably at lower altitudes in a wide range of environmental conditions. The Loitering Munitions Systems segment focuses primarily on tube-launched aircraft that deploy with the push of a button, fly at higher speeds than small UAS products, and perform either effects delivery or reconnaissance missions, and related support services including training, spare parts, product repair, and product replacement. The MacCready Works segment focuses on customer-funded research and development in the areas of HAPS, robotics, sensors, software analytics, data intelligence, and connectivity. The company was founded by Paul B. MacCready, Jr. in July 1971 and is headquartered in Arlington, VA.

AeroVironment Inc.

AeroVironment is seeing extreme volatility and a major sell-off following a Raymond James downgrade, fueled by the U.S. Space Force's decision to re-compete the critical $1.4 billion SCAR program, leaving the community debating whether the contract is lost or merely undergoing renegotiation for this drone defense leader.

Red Cat Holdings, Inc. provides products, services and solutions to the drone industry. It also engages in the provision of distributed data storage, analytics and services for the drone industry.The firm product include Dronebox, which is a blockchain technology that records, stores and analyzes flight data and information from a drone. It operates through the Enterprise Segment. The Enterprise Segment will focus on developing a hardware enabled software platform of services and solutions to government and commercial enterprises and the military. The company was founded by Jeffrey M. Thompson in February 1984 and is headquartered in San Juan, Puerto Rico.

Red Cat Holdings Inc

Red Cat Holdings is a central topic of discussion amid rising geopolitical tensions and the US Army's "Drone Dominance Program," with the community actively speculating on unprecedented demand for its drone and robotic solutions. Recent institutional boosts and public endorsements from military figures are fueling excitement for potential significant government contracts.

United States Antimony Corp. engages in the extraction, processing and sale of antimony, zeolite, silver, and gold products. It operates through the following segments: United States Antimony Operations, Mexican Antimony Operations, Precious Metals Recovery, and United States Zeolite Operations. The company was founded by John C. Lawrence in June 1968 and is headquartered in Thompson Falls, MT.

United States Antimony Corp.

United States Antimony Corp

United States Antimony Corp. is trending as escalating geopolitical tensions are amplifying urgent discussions around domestic critical mineral supply chains for military munitions. The community is highlighting UAMY's unique position as the only US antimony producer, anticipating government contracts and funding to secure this vital resource amidst global supply pressures.

Berkshire Hathaway, Inc. is a holding company, which engages in the provision of property and casualty insurance and reinsurance, utilities and energy, freight rail transportation, finance, manufacturing, and retailing services. It operates through the following segments: Insurance, Burlington Northern Santa Fe, LLC (BNSF), Berkshire Hathaway Energy (BHE), Pilot Travel Centers (PTC), Manufacturing, McLane, and Service and Retailing. The Insurance segment includes the underwriting of GEICO, Berkshire Hathaway Primary Group, and Berkshire Hathaway Reinsurance Group. The BNSF segment involves the operation of railroad systems. The BHE segment focuses on regulated electric and gas utility, power generation and distribution, and real estate brokerage activities. The PTC segment consists of managing travel centers and marketing of wholesale fuel. The Manufacturing segment refers to industrial, consumer and building products, home building, and related financial services. The McLane segment covers the wholesale distribution of groceries and non-food items. The Service and Retailing segment relates to the provision of shared aircraft ownership programs, aviation pilot training, electronic components distribution, retailing businesses, automobile dealerships and trailer, and furniture leasing services. The company was founded by Oliver Chace in 1839 and is headquartered in Omaha, NE.

Berkshire Hathaway Inc. - Ordinary Shares - Class B

Berkshire Hathaway is trending as recent weaker operating earnings and a substantial cash pile fuel community debate over whether the leadership transition to Greg Abel signals a shift towards more active capital deployment or if the conglomerate risks its "safe haven" reputation amidst market volatility.

Venture Global, Inc. engages in the development and construction of liquefied natural gas production, establishing us as a rapidly growing company delivering critical LNG to the world. It projects include Calcasieu, Plaquemines, CP2, CP3 and Delta projects. The company was founded by Michael Sabel and Robert Pender in 2023 and is headquartered in Arlington, VA.

Venture Global Inc. - Ordinary Shares - Class A

Venture Global Inc

Venture Global is trending as escalating Middle East tensions, including a halt in Qatar's LNG production, drive a sharp rise in global natural gas prices, favorably positioning the company's significant spot market exposure and rapidly expanding capacity. The community remains bullish, actively discussing its long-term value and project milestones like CP2, often viewing recent analyst downgrades as attempts to acquire cheaper shares.

POET Technologies, Inc. engages in the designing, developing, manufacturing and sale of opto-electronic solutions for the sensing, data communications and telecommunications markets. It developed POET Optical Interposer platform, which allows the integration of electronic and photonic devices into a single multi-chip module. The company was founded on November 14, 1985 and is headquartered in Toronto, Canada.

POET Technologies Inc

Speculation is rampant around POET Technologies as NVIDIA's increasing focus on optical interconnects for AI data centers and Marvell's acquisition of Celestial AI validate the photonics sector, with the community anticipating significant partnership announcements and a revenue ramp, potentially coinciding with the upcoming OFC conference.

SELLAS Life Sciences Group, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of immunotherapeutic for cancer indications. Its product pipeline includes galinpepimut-S. The company was founded by Angelos M. Stergiou on April 3, 2006 and is headquartered in New York, NY.

SELLAS Life Sciences Group Inc

SELLAS Life Sciences is seeing significant upward momentum driven by intense anticipation for its Phase 3 REGAL trial results for the cancer therapy GPS, which many in the community believe will show overwhelming efficacy due to the extended trial duration. This sentiment, combined with strong speculation of an imminent short squeeze and a potential buyout by a major pharmaceutical firm, is fueling a fierce battle around the $5 price level.

Xeris Biopharma Holdings, Inc. is a biopharmaceutical company, which engages in developing and commercializing products across a range of therapies. The company has three commercial products: Gvoke, Keveyis, and Recorlev. Gvoke is ready-to-use liquid glucagon for the treatment of severe hypoglycemia. Keveyis is the therapy approved in the United States to treat hyperkalemic, hypokalemic, and related variants of primary periodic paralysis (PPP). Recorlev is a cortisol synthesis inhibitor approved for the treatment of endogenous hypercortisolemia in adult patients with Cushing’s syndrome. Its product also includes Ogluo which is used for the treatment of severe hypoglycemia in adults, adolescents, and children aged 2 years and over with diabetes mellitus. The company was founded by Steven Prestrelski in 2005 and is headquartered in Chicago, IL.

Xeris Biopharma Holdings Inc

Xeris Biopharma is trending after delivering a strong Q4 earnings beat and optimistic 2026 revenue guidance, significantly amplified by a competitor's FDA rejection for a Cushing's syndrome drug, which positions Recorlev for expanded market leadership. Despite an apparent market overreaction, the community sees this as a prime buying opportunity given the company's high gross margins, path to profitability, and advancing blockbuster pipeline.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Nautilus Biotechnology (NASDAQ:NAUT) Price Target Raised to $4.00 at Guggenheim

Guggenheim upped their target price on Nautilus Biotechnology from $2.50 to $4.00 and gave the stock a "buy" rating in a report on Friday...

Nautilus Biotechnology Q4 Earnings Call Highlights

Nautilus Biotechnology (NASDAQ:NAUT) used its fourth-quarter 2025 earnings call to highlight recent steps toward commercialization of its proteomics platform, alongside continued cost reductions and...

Nautilus Biotechnology (NASDAQ:NAUT) Announces Earnings Results

Nautilus Biotechnology (NASDAQ:NAUT - Get Free Report) released its earnings results on Thursday. The company reported ($0.11) earnings per share for the quarter, beating the consensus estimate of...

Nautilus Biotechnology (NAUT) to Release Earnings on Thursday

Nautilus Biotechnology (NASDAQ:NAUT) will be releasing its Q4 2025 earnings before the market opens on Thursday, February 26. (View Earnings Report at...

Short Interest in Nautilus Biotechnology, Inc. (NASDAQ:NAUT) Decreases By 16.6%

Nautilus Biotechnology, Inc. (NASDAQ:NAUT - Get Free Report) saw a significant drop in short interest during the month of January. As of January 30th, there was short interest totaling 307,305...

Nautilus Biotechnology (NASDAQ:NAUT) Stock Price Up 6.3% - What's Next?

Nautilus Biotechnology (NASDAQ:NAUT) Stock Price Up 6.3% - Here's Why...

Nautilus Biotechnology (NASDAQ:NAUT) Stock Price Up 0.5% - Here's What Happened

Nautilus Biotechnology (NASDAQ:NAUT) Shares Up 0.5% - What's Next...

Wall Street Zen Upgrades Nautilus Biotechnology (NASDAQ:NAUT) to Hold

Wall Street Zen raised shares of Nautilus Biotechnology from a "sell" rating to a "hold" rating in a research report on Tuesday...

Wall Street Zen Downgrades Nautilus Biotechnology (NASDAQ:NAUT) to Sell

Wall Street Zen downgraded shares of Nautilus Biotechnology from a "hold" rating to a "sell" rating in a report on Monday...

Nautilus Biotechnology, Inc. is a development stage life sciences company, which creates platform technology for quantifying and unlocking the complexity of the proteome. Its products include Proteome Analysis System, Reagent Kits, and Software and Analysis. The company was founded by Sujal M. Patel and Parag Mallick in 2016 and is headquartered in Seattle, WA.

Nautilus Biotechnology Inc

Beat EPS and revenue

Beat EPS, miss revenue

Miss EPS, beat revenue

Miss EPS and revenue

What do you expect from $MDB earnings today?

Fiscal Period	Estimated	Reported	Surprise	Result
Q1 '26	-$0.14	--	--	N/A
Q4 '25	-$0.14	-$0.11	21.43%	BEAT
Q3 '25	-$0.15	-$0.11	26.67%	BEAT
Q2 '25	-$0.16	-$0.12	22.58%	BEAT
Q1 '25	-$0.15	-$0.13	10.96%	BEAT

NAUT
Nautilus Biotechnology Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest Earnings Results: Q4 '25

Historical Earnings

Latest NAUT News

NAUTNautilus Biotechnology Inc